Keisuke
Tanaka
a,
Yuuya
Kasahara
*ab,
Yoichi
Miyamoto
b,
Takumi
Okuda
a,
Tatsuro
Kasai
c,
Kentaro
Onodera
c,
Masayasu
Kuwahara
cd,
Masahiro
Oka
b,
Yoshihiro
Yoneda
b and
Satoshi
Obika
ab
aGraduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan
bNational Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan. E-mail: y-kasahara@nibiohn.go.jp
cGraduate School of Science and Technology, Gunma University, Gunma 376-8515, Japan
dGraduate School of Integrated Basic Sciences, Nihon University, Tokyo 156-8550, Japan
First published on 4th October 2018
Correction for ‘Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1′ by Keisuke Tanaka et al., Org. Biomol. Chem., 2018, 16, 4456–4463.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2018 |